Literature DB >> 15860286

Comparing age-related macular degeneration phenotype in probands from singleton and multiplex families.

Eric A Postel1, Anita Agarwal, Silke Schmidt, Yu-Ti R Fan, William K Scott, John R Gilbert, Jonathan L Haines, Margaret A Pericak-Vance.   

Abstract

PURPOSE: To compare age-related macular degeneration (AMD) phenotype between probands in singleton and multiplex families to determine whether data from these two groups may be combined for consolidated genetic analyses.
DESIGN: Retrospective case-control study.
METHODS: Individuals 55 years of age or older with AMD were identified. Complete histories and examinations were recorded, 35-mm fundus photographs obtained, and macular findings graded. Detailed information was recorded, including the presence of extramacular and peripheral drusen, peripheral reticular pigmentary change, posterior vitreous detachment, and iris color. Comparisons were performed between probands from singleton and multiplex families.
RESULTS: There was no statistically significant difference in grade between the 411 singleton and 125 multiplex probands (P = .52), and the distribution of grades was similar between the two groups. No statistically significant difference was found between proband groups with respect to the presence or extent of small (P = .48), intermediate (P = .72), and large drusen (P = .74) and retinal pigment epithelium hyper- (P = .76) and hypopigmentation (P = .55); in the presence or grade of peripheral reticular pigment change; the presence of geographic atrophy in exudative disease, extramacular drusen, or posterior vitreous detachment; lens status; iris color; visual acuity; intraocular pressure; optic nerve cupping; and body mass index. A statistically significant difference between the two groups was noted in the presence of peripheral drusen (P = .0001).
CONCLUSIONS: Singleton and multiplex AMD probands share a similar phenotype. This suggests that multiplex and singleton data can be combined for consolidated genetic analyses.

Entities:  

Mesh:

Year:  2005        PMID: 15860286     DOI: 10.1016/j.ajo.2004.12.029

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  6 in total

1.  Inverse association of female hormone replacement therapy with age-related macular degeneration and interactions with ARMS2 polymorphisms.

Authors:  Digna R Velez Edwards; Paul Gallins; Monica Polk; Juan Ayala-Haedo; Stephen G Schwartz; Jaclyn L Kovach; Kylee Spencer; Gaofeng Wang; Anita Agarwal; Eric A Postel; Jonathan L Haines; Margaret Pericak-Vance; William K Scott
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-20       Impact factor: 4.799

2.  Comparison of morphology of human macular and peripheral Bruch's membrane in older eyes.

Authors:  Mark Johnson; Arun Dabholkar; Jiahn-Dar Huang; J Brett Presley; Melissa F Chimento; Christine A Curcio
Journal:  Curr Eye Res       Date:  2007-09       Impact factor: 2.424

3.  Using genetic variation and environmental risk factor data to identify individuals at high risk for age-related macular degeneration.

Authors:  Kylee L Spencer; Lana M Olson; Nathalie Schnetz-Boutaud; Paul Gallins; Anita Agarwal; Alessandro Iannaccone; Stephen B Kritchevsky; Melissa Garcia; Michael A Nalls; Anne B Newman; William K Scott; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  PLoS One       Date:  2011-03-24       Impact factor: 3.240

4.  Swept-source optical coherence tomography findings in peripheral drusen.

Authors:  Vinod Kumar; Ruchir Tewari; Parijat Chandra; Atul Kumar
Journal:  Indian J Ophthalmol       Date:  2016-12       Impact factor: 1.848

Review 5.  Perspective on AMD Pathobiology: A Bioenergetic Crisis in the RPE.

Authors:  Cody R Fisher; Deborah A Ferrington
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-03-20       Impact factor: 4.799

6.  Mitochondrial DNA polymorphism A4917G is independently associated with age-related macular degeneration.

Authors:  Jeffrey A Canter; Lana M Olson; Kylee Spencer; Nathalie Schnetz-Boutaud; Brent Anderson; Michael A Hauser; Silke Schmidt; Eric A Postel; Anita Agarwal; Margaret A Pericak-Vance; Paul Sternberg; Jonathan L Haines
Journal:  PLoS One       Date:  2008-05-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.